Criterion #,Criterion,Max Score,Satisfaction (%),Score Awarded,Rationale
1,"Reward for capturing in the History of Present Illness that the patient is inconsistently taking mesalamine, including approximate frequency of missed doses and the associated return of Crohn’s symptoms",20,5.0,1.0,"Mesalamine is listed but there is no mention of missed doses, frequency of non-adherence, or symptom recurrence."
2,Reward for documenting the patient’s engagement in specific adherence strategies (phone reminders found ineffective and plan to try a pill organizer) within the Plan or Instructions,15,0.0,0.0,No reference to phone reminders or pill organizer in Plan/Instructions.
3,Reward for providing an evidence-based assessment of Crohn’s disease control and decision to continue mesalamine maintenance therapy consistent with clinical guidelines,15,5.0,0.75,No assessment of Crohn’s control or rationale to continue mesalamine therapy.
4,"Reward for recording clear patient-safety instructions to report any new symptoms, medication side effects, or disease flare promptly",15,0.0,0.0,"No instructions to report new symptoms, side effects, or flares."
5,Reward for specifying a concrete follow-up plan or timeline to reassess medication adherence and disease status,10,0.0,0.0,Note lacks any follow-up timeline to reassess adherence or disease status.
6,Penalize for omission or inaccurate documentation of the current medication name and dose (mesalamine 2.4 g daily) or for failing to note allergies when relevant,15,85.0,-12.75,Medication name given but dose (2.4 g daily) omitted and allergies not documented.
7,"Penalize for inclusion of redundant, boiler-plate, or clinically irrelevant content not supported by the encounter transcript",10,10.0,-1.0,Very brief note; only mild boiler-plate phrasing (‘take as directed’); little irrelevant content.
